Literature DB >> 16530295

Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: Evidence for delayed up-regulation and redistribution of GLT-1.

Ross D O'Shea1, Chew L Lau, Mark C Farso, Shanti Diwakarla, Chrissandra J Zagami, Brian B Svendsen, Sandra J Feeney, Jennifer K Callaway, Nicole M Jones, David V Pow, Niels C Danbolt, Bevyn Jarrott, Philip M Beart.   

Abstract

Excitatory amino acid transporters (EAATs) are responsible for homeostasis of extracellular L-glutamate, and the glial transporters are functionally dominant. EAAT expression or function is altered in acute and chronic neurological conditions, but little is known about the regulation of EAATs in reactive astroglia found in such neuropathologies. These studies examined the effects of the bacterial endotoxin lipopolysaccharide (LPS) on glial EAATs in vitro. The effects of LPS (1 microg/ml, 24-72 h) on EAAT activity and expression were examined in primary cultures of mouse astrocytes. [(3)H]D-aspartate uptake increased to 129% of control by 72 h treatment with LPS. Saturation analysis revealed that apparent K(m) was unchanged whilst V(max) was significantly increased to 172% of control by 72 h LPS treatment. Biotinylation and Western blotting indicated that cell-surface expression of GLT-1 was significantly elevated (146% control) by LPS treatment whereas GLAST expression was unchanged. Confocal analyses revealed that LPS treatment resulted in cytoskeletal changes and stellation of astrocytes, with rearrangement of F-actin (as shown by phalloidin labelling). Immunocytochemistry revealed clustering of GLAST, and increased expression and redistribution of GLT-1 to the cell-surface following treatment with LPS. Similar experiments were conducted in microglia, where LPS (50 ng/ml) was found to up-regulate expression of GLT-1 at 24 and 72 h in concert with cytoskeletal changes accompanying activation. These findings suggest an association of cytoskeletal changes in glia with EAAT activity, with the predominant adaptation involving up-regulation and redistribution of GLT-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530295     DOI: 10.1016/j.neuint.2005.12.028

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  16 in total

1.  Naloxone and ouabain in ultralow concentrations restore Na+/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes.

Authors:  Johan Forshammar; Linda Block; Christopher Lundborg; Björn Biber; Elisabeth Hansson
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

Review 2.  Targeted activation of astrocytes: a potential neuroprotective strategy.

Authors:  Carole Escartin; Gilles Bonvento
Journal:  Mol Neurobiol       Date:  2008-10-18       Impact factor: 5.590

3.  Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline.

Authors:  Arpita Sharma; Nisha Patro; Ishan K Patro
Journal:  Cell Mol Neurobiol       Date:  2015-07-19       Impact factor: 5.046

4.  Characterization of primary and secondary cultures of astrocytes prepared from mouse cerebral cortex.

Authors:  Dorte M Skytt; Karsten K Madsen; Kamilla Pajęcka; Arne Schousboe; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

5.  Transportable and non-transportable inhibitors of L-glutamate uptake produce astrocytic stellation and increase EAAT2 cell surface expression.

Authors:  Chew L Lau; Philip M Beart; Ross D O'Shea
Journal:  Neurochem Res       Date:  2010-02-09       Impact factor: 3.996

6.  Neuronal expression of splice variants of "glial" glutamate transporters in brains afflicted by Alzheimer's disease: unmasking an intrinsic neuronal property.

Authors:  David V Pow; David G Cook
Journal:  Neurochem Res       Date:  2009-03-25       Impact factor: 3.996

7.  Evidence group I mGluR drugs modulate the activation profile of lipopolysaccharide-exposed microglia in culture.

Authors:  Mark C Farso; Ross D O'Shea; Philip M Beart
Journal:  Neurochem Res       Date:  2009-05-29       Impact factor: 3.996

Review 8.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

9.  Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia.

Authors:  Tara M Desilva; Saraid S Billiards; Natalia S Borenstein; Felicia L Trachtenberg; Joseph J Volpe; Hannah C Kinney; Paul A Rosenberg
Journal:  J Comp Neurol       Date:  2008-05-10       Impact factor: 3.215

Review 10.  Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.

Authors:  Z Martinez-Lozada; A M Guillem; M B Robinson
Journal:  Adv Pharmacol       Date:  2016-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.